Aquabounty Technologies, Inc. · NASDAQ:AQB
Aquabounty Technologies — IPO Roadshow (December 2017)
24 slides from Aquabounty Technologies's IPO roadshow presentation, Dec 7, 2017
Slide 1: AquaBounty Technologies Issuer Free Writing Prospectus
AquaBounty Technologies Filed pursuant to Rule 433 of the Securities Act of 1933 Issuer Free Writing Prospectus dated December 7, 2017 Relating to Preliminary Prospectus dated December 7, 2017 Registration No. 333-221435
Slide 2: Forward-Looking Statements Safe Harbor Statement
Forward-Looking Statements Safe Harbor Statement Some of the statements made in this presentation involve risks and uncertainties that are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements are based upon Aqua
Slide 3: Overview
Overview AquaBounty Technologies, Inc. Biotechnology company focused on enhancing productivity in the $176b1 aquaculture market through genetic modification and other molecular biologic techniques. First product, AquAdvantage® Salmon (AAS) - a faster-growing Atlantic salmon, has been approved by the
Slide 4: The Technology – AquAdvantage Salmon
Selection Milt Non-transgenic Progeny Transgenic Founder Transgene DNA Microinjection Fertilized Microinjected Eggs Promoter Terminator GH cDNA TATA TAG ATG AATAA // // 1989 1992 1994 1996 1998 2000 2002 Microinject P 1 F 1 F 2 F 3 F 4 F 5 2004 2006 2008 F 6 F 7 F 8 2016 F12 The Technology – AquAdva
Slide 5: The Technology - Land-based Aquaculture
The Technology - Land-based Aquaculture AAS enables this land-based, environment-friendly production system to be economically viable versus current sea-cage production systems. AAS will be raised in Recirculating Aquaculture Systems (RAS) away from the ocean, eliminating the risk of ocean-borne pol
Slide 6: Global Markets and Growth Drivers
Global Markets and Growth Drivers
Slide 7: Aquaculture Market
Sources: FAO FIPS (2014) // Fish to 2030 (2013) Fish is a healthy food and an efficient source of high quality protein. Many of the world’s fisheries are already fully exploited. Aquaculture must double just to hold current per capita fish consumption constant. Aquaculture Market Aquaculture growth
Slide 8: Atlantic Salmon Market – Global
(Source: Kontali – Salmon World 2017) in metric tons Atlantic Salmon Market – Global Trade Worldwide Atlantic salmon market in 2015 = 2.4m metric tons worth $12 billion (Source: FAO) North America: Harvest: 182,500 Market517,400 Latin America: Harvest: 698,700 Market: 163,800 Norway, Faroe Islands,
Slide 9: Atlantic Salmon Market – U.S. Opportunity
3% 280,000 TONS $2.7B of all Atlantic salmon consumed in the U.S. is produced domestically of Atlantic salmon were imported in 2016 total U.S. market opportunity Atlantic Salmon Market – U.S. Opportunity (Source: U.S. Department of Commerce)
Slide 10: AquAdvantage Salmon Features and Benefits
AquAdvantage Salmon Features and Benefits
Slide 11: AquAdvantage Salmon - Features and Benefits
FASTER GROWTH +Reaches harvest weight in 18-to-20 months BETTER FEED CONVERSION +25% better feed conversion than non-transgenic siblings +Less feed required to reach market weight +Could operate with plant-based, sustainable feed SHORTER TRANSPORTATION DISTANCE +Reduces cost and carbon footprint LAN
Slide 12: Faster Growth
Accelerated growth allows AquAdvantage® Salmon (AAS) to reach harvest weight sooner. Below: Genetically modified salmon (rear) and non-genetically modified salmon (foreground) at the same age. FASTER GROWTH AAS grow faster than standard Atlantic salmon - specifically during early rearing. However, A
Slide 13: Better Feed Conversion
Atlantic salmon already have a better feed conversion rate than other sources of protein. And AAS have a 25% better feed conversion rate1 than standard Atlantic salmon. AAS consume more feed on a daily basis, but due to enhanced growth rates, better feed conversion ratios and higher nitrogen retenti
Slide 14: Shorter Transportation Distance
SHORTER TRANSPORTATION DISTANCE Reduces cost and carbon footprint 3,200 miles 500 miles 3,600 miles
Slide 15: Land-Based Production
LAND-BASED PRODUCTION Significant advantages over current main method of fish farming Optimized growing conditions & fish health Biosecurity - reduced exposure to pathogens & parasites. Limited need for antibiotics or medications Clean groundwater - reduced exposure to environmental contaminants Con
Slide 16: Commercialization Program
Commercialization Program
Slide 17: Consumer Benefits
Fresh Atlantic salmon produced close to home Atlantic salmon is a safe and healthy source of omega-3s Sustainable and responsible seafood choice Consumer Benefits
Slide 18: Commercial Roll-Out
First sale of AAS in June 2017 10 metric tons of AAS from the Panama site were harvested, processed yielding 5 metric tons of fillets and shipped to Canada. The response from the buyers was very enthusiastic and they are eager to receive more product. The sale was made at market rate ($5.28/lb) for
Slide 19: Marketing Plan
Initial strategy: AAS will be sold through established distributors. Longer-term strategy: Once AAS is established in the market, the option for branding as a “sustainably produced” food item can be considered. Marketing Plan
Slide 20: Grow-Out Facilities
US - Indiana Purchased first commercial-scale operating site for AAS in the US from Bell Fish Company in 2017. Facility is currently being renovated and upgraded to improve capacity to 1,200 metric tons annually. First eggs expected to be introduced in 2018. First harvest expected in late 2019. Cana
Slide 21: International Business Development
Brazil Currently running a field trial in support of an application to approve AAS. Argentina Currently running a field trial in support of an application to approve AAS. Chile Signed an agreement with a local partner in Chile on the regulatory application for AAS. China Submitted application to run
Slide 22: Management Team
Management Team Ronald L. Stotish, Ph.D. was appointed an Executive Director, President and CEO of AquaBounty Technologies in May 2008 after joining the company in 2006 as Vice President for Regulatory Affairs. Prior to joining AquaBounty, Dr. Stotish was Executive Vice President for R&D at MetaMorp
Slide 23: Shares Outstanding and Financial Data
23 Shares outstanding at September 30, 2017 = 8,895,094 Financial data
Slide 24: Summary
The aquaculture industry must double its output in the next 30 years to meet growing market demand (Source: FAO). AquAdvantage Salmon enables the viability of the land-based production method needed to meet the market demand. AquAdvantage Salmon provides the technology to bring a profitable and sust
AquaBounty Technologies — IPO Roadshow (December 2017) on 6ix